• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    ProLynx Publishes Once Monthly Semaglutide in PNAS

    PR NEWSWIRE

    ProLynx announces of the Ph II Topology trial of its DNA-damaging agent PLX03

    GLOBENEWSWIRE

    ProLynx announces initiation of Phase I/II trial of DNA-damaging agent PLX038

    GLOBENEWSWIRE

    ProLynx announces a publication proposing that a long-acting prodrug of SN-38 could be effective in treating Sacituzumab Govitecan-Resistant Tumors

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.